Showing results (141-150 of 160) with videos related to
Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed GlioblastomaStefano Indraccolo, Giuseppe Lombardi, Matteo Fassan, et al.Journal of Experimental & Clinical Cancer Research : CR|December 20, 2024
Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX modelsDaniele Boso, Ilaria Piga, Chiara Trento, et al.The Lancet. Oncology|December 8, 2018
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trialGiuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical PresentationFrancesca Orzan, Francesca De Bacco, Elisabetta Lazzarini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and BevacizumabLaura Bonanno, Angela De Paoli, Elisabetta Zulato, et al.Journal of Experimental & Clinical Cancer Research : CR|August 7, 2023
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenograftsDaniele Boso, Martina Tognon, Matteo Curtarello, et al.Cancer Research|November 9, 2014
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cellsMatteo Curtarello, Elisabetta Zulato, Giorgia Nardo, et al.Haematologica|October 2, 2025
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathwayGiulia Veltri, Alberto Peloso, Alice Cani, et al.Cancers|August 23, 2020
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot StudyGiuseppe Lombardi, Valeria Barresi, Stefano Indraccolo, et al.Molecular Diagnosis & Therapy|June 17, 2026
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid BiopsyFederico Rojo, Valentina Guarneri, Nicola Fusco, et al.Pageof 16